Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer - PubMed (original) (raw)
Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer
Xiao-Mei Zhang et al. World J Gastroenterol. 2003 Aug.
Abstract
Aim: NGX6, NAG-7 and BRD7 genes are tumor related genes, which have been newly cloned by positional candidate cloning strategy. This study was designed to investigate the expression levels of NGX6, NAG-7 and BRD7 genes in human gastric and colorectal cancer tissues, and their corresponding normal tissues, and to investigate whether these genes play a role in the pathogenesis of gastric and colorectal cancers.
Methods: Reverse transcription-polymerase chain reaction (RT-PCR), dot hybridization and Northern blot analysis were used to compare the expression levels of NGX6, NAG-7 and BRD7 genes in 34 gastric cancer tissues and 34 colorectal cancer tissues with their corresponding normal tissues of the same patients, respectively.
Results: Among the 34 colorectal cancer specimens and the 34 gastric cancer specimens, the expression of NGX6 in 25 colorectal cancer tissues was absent or very weak (73.5 %) by RT-PCR analysis. The down-regulation rate of NGX6 in colorectal cancer tissues was significantly higher than that in corresponding normal tissues (26.5 %,9/34) (P<0.005). Moreover, the down-regulation of NGX6 was significantly correlated with lymph node and/or distance metastases. Patients with lymph node and/or distance metastasis had much higher down-regulation rate of NGX6 than patients without metastases (93.8 % vs 55.6 %, P<0.05). However no correlation was found between the expression of NGX6 and pathologic type of colorectal cancer in this study, and also the expression of NGX6 did not display any difference between gastric cancer and corresponding normal tissues (58.8 % vs 70.6 %, P>0.25). Dot hybridization and Northern blot analysis confirmed the results of RT-PCR. Furthermore, NAG-7 and BRD7 mRNA was not up- or down-regulated in gastric and colorectal cancers compared with their corresponding normal tissues in our study.
Conclusion: The down-regulation of NGX6 may be closely associated with tumorigenesis and metastasis of colorectal carcinoma. However, it may not contribute to the development and progression of gastric carcinoma. In addition, the expression levels of NAG-7, and BRD7 did not alter in gastric and colorectal cancers. This seems to suggest that NAG-7 and BRD7 genes may not play a role in gastric and colorectal carcinogenesis.
Figures
Figure 1
Expression of NGX6 in colorectal carcinoma and its corresponding normal tissues was examined by RT-PCR. The RT-PCR products with NGX6 primers produced 780 bp frag-ments and GAPDH primers produced 466 bp fragments. Lane M, DL-2000 marker; Lane N, normal tissues; Lane C, colorectal carcinoma tissues. This figure showed the representative re-sults from several individual patients.
Figure 2
Northern blot was used to detect the expression abun-dance of NGX6 gene in human colorectal carcinoma and its adjacent normal tissues. The expression level of NGX6 was down-regulated in colorectal carcinoma tissues. C, human colorectal carcinoma tissue; N, adjacent normal colorectal tissue.
Similar articles
- NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M, Peng Y, Wang X, Guo Q, Shen S, Li G. Liu M, et al. BMC Cancer. 2010 Apr 27;10:160. doi: 10.1186/1471-2407-10-160. BMC Cancer. 2010. PMID: 20423473 Free PMC article. - NGX6 inhibits AP-1 and Ets-1 expression and down-regulates cyclin D1 in human colorectal cancer.
Peng Y, Li H, Wu M, Wang X, Fan S, Liu F, Xiang B, Guo Q, Tang X, Shen S. Peng Y, et al. Acta Biochim Biophys Sin (Shanghai). 2009 Jun;41(6):504-14. doi: 10.1093/abbs/gmp039. Acta Biochim Biophys Sin (Shanghai). 2009. PMID: 19499154 - Expression of 2 transcripts of NGX6 gene in colorectal cancer and the correlation with carcinoembryonic antigen.
Su Z, Wang X, Shen S, Wang L, Li Y, Li N, Li Z. Su Z, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 May;35(5):401-8. doi: 10.3969/j.issn.1672-7347.2010.05.001. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20543461 - Tumor suppressor NGX6 inhibits the growth and metastasis of multiple cancers.
He S, Zhong Y, Shuai C, Gao D, Wei P, Li G, Peng S. He S, et al. Tumour Biol. 2016 May;37(5):5751-60. doi: 10.1007/s13277-016-4966-5. Epub 2016 Feb 15. Tumour Biol. 2016. PMID: 26880583 Review. - BRD7: a novel tumor suppressor gene in different cancers.
Yu X, Li Z, Shen J. Yu X, et al. Am J Transl Res. 2016 Feb 15;8(2):742-8. eCollection 2016. Am J Transl Res. 2016. PMID: 27158366 Free PMC article. Review.
Cited by
- Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer.
Eskandari-Nasab E, Hashemi M, Rezaei H, Fazaeli A, Mashhadi MA, Moghaddam SS, Arbabi F, Jahantigh M, Taheri M. Eskandari-Nasab E, et al. Mol Biol Rep. 2012 Dec;39(12):10531-9. doi: 10.1007/s11033-012-1938-8. Epub 2012 Oct 7. Mol Biol Rep. 2012. PMID: 23053953 - Identification of skin-related lncRNAs as potential biomarkers that involved in Wnt pathways in keloids.
Sun XJ, Wang Q, Guo B, Liu XY, Wang B. Sun XJ, et al. Oncotarget. 2017 May 23;8(21):34236-34244. doi: 10.18632/oncotarget.15880. Oncotarget. 2017. PMID: 28404955 Free PMC article. - Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells.
Wang XY, Wu MH, Liu F, Li Y, Li N, Li GY, Shen SR. Wang XY, et al. Mol Cell Biochem. 2010 Dec;345(1-2):283-90. doi: 10.1007/s11010-010-0582-7. Epub 2010 Sep 22. Mol Cell Biochem. 2010. PMID: 20859756 - Genetic and molecular biology of breast cancer among Iranian patients.
Moghbeli M. Moghbeli M. J Transl Med. 2019 Jul 8;17(1):218. doi: 10.1186/s12967-019-1968-2. J Transl Med. 2019. PMID: 31286981 Free PMC article. Review. - MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma.
Niu M, Gao D, Wen Q, Wei P, Pan S, Shuai C, Ma H, Xiang J, Li Z, Fan S, Li G, Peng S. Niu M, et al. BMC Cancer. 2016 Mar 15;16:218. doi: 10.1186/s12885-016-2253-x. BMC Cancer. 2016. PMID: 26975503 Free PMC article.
References
- Yu J P, Dong WG. Current situation about early diagnosis of can-cer of large intestine. Shijie Huaren Xiaohua Zazhi. 1999;7:553–554.
- Fiocca R, Luinetti O, Villani L, Mastracci L, Quilici P, Grillo F, Ranzani GN. Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype. Hepatogastroenterology. 2001;48:1523–1530. - PubMed
- Yustein AS, Harper JC, Petroni GR, Cummings OW, Moskaluk CA, Powell SM. Allelotype of gastric adenocarcinoma. Cancer Res. 1999;59:1437–1441. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases